ROY.PHILIPS (PHI1 MU) stock market data APIs
€22.9027
0.08(0.3%)
as of December 30, 2025
Try our APIs with
free plan!
ROY.PHILIPS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for PHI1.MU.
Prev. Close
22.9027
Open
22.9791
High
23.0259
Low
22.9007
52 wk Range
18.1607-26.4627
Market Cap
27 705 M
Dividends (Yield)
0.0388
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get ROY.PHILIPS data using free add-ons & libraries
Get ROY.PHILIPS Fundamental Data
ROY.PHILIPS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
ROY.PHILIPS News
New
Europe Image-Guided Drug Delivery Market Forecast and Research Report 2025-2035 Featuring Renishaw, Neurochase, and Koninklijke Philips
Company Logo The Europe Image-Guided Drug Delivery (IGDD) market is set to surge from $13.7 million in 2024 to $284.1 million by 2035, exhibiting a CAGR of 32.01%. This growth is propelled by advance...
3 Hyped Up Stocks We Approach with Caution
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro develo...
Does Philips Share Price Reflect Its Recovery Prospects Amid Ongoing Product Quality Settlements?
If you have been wondering whether Koninklijke Philips is quietly becoming a value opportunity or still a recovery story in progress, you are not alone. This article will help you cut through the nois...
Liom achieves Breakthrough in Miniaturization of its Non-invasive Biomarker Monitoring Tech Platform and extends Series A Funding to CHF 38 Million
Leo Grünstein (Founder & CEO) in Liom's labLeo Grünstein (Founder & CEO) in Liom's lab Pfäffikon, Switzerland, Dec. 18, 2025 (GLOBE NEWSWIRE) -- Liom, a pioneer in non-invasive biomarker monitorin...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
